GDRX Jan 2026 7.500 put
| Previous close | 1.5500 |
| Open | 1.5500 |
| Bid | 0.7000 |
| Ask | 1.9000 |
| Strike | 7.50 |
| Expiry date | 2026-01-16 |
| Day's range | 1.5500 - 1.5500 |
| Contract range | N/A |
| Volume | |
| Open interest | 304 |
Business WireGoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)
SANTA MONICA, Calif., September 26, 2024--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is working with ARS Pharmaceuticals, Inc. ("ARS Pharmaceuticals") to offer the lowest discounted cash price for neffy® in retail pharmacy locations. Available for purchase in-store this week, consumers who have been prescribed neffy can now access a pack of two single-use neffy devices for $199 at more than 70,000 pharmacies nationwide exclusively through Goo
Yahoo FinanceWhy Big Pharma is betting on telehealth strategies
The telehealth world is entering a new phase of vertical integration in healthcare.
Simply Wall St.High Growth Tech Stocks To Watch In The United States
The market is up 1.2% over the last week, with the Information Technology sector up 1.0%. In the last year, the market has climbed 26%, and earnings are forecast to grow by 15% annually. In this favorable environment, identifying high growth tech stocks that can leverage these trends is crucial for investors seeking robust returns.
